09:22 AM EDT, 06/24/2024 (MT Newswires) -- Health care stocks were advancing premarket Monday as the iShares Biotechnology ETF ( IBB ) was 1.3% higher and the Health Care Select Sector SPDR Fund ( XLV ) was up 0.3% recently.

Alimera Sciences ( ALIM ) was surging past 77% after ANI Pharmaceuticals ( ANIP ) said it agreed to acquire the company in a deal valued at around $381 million.

Argenx (ARGX) was up almost 11% after saying the US Food and Drug Administration has approved Vyvgart Hytrulo for the treatment of adult patients with chronic inflammatory demyelinating polyneuropathy, a neuromuscular disorder that causes a range of disabling mobility and sensory issues.

G1 Therapeutics ( GTHX ) fell by over 42% after saying it is winding down the phase 3 study of its experimental drug, trilaciclib, administered before chemotherapy in patients with a type of breast cancer after it failed to show statistically significant treatment effect compared to the control arm.